Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Hide Studies Not Open or Pending
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Condition(s):Gut MicrobiomeLast Updated:January 9, 2019Unknown status
Condition(s):VitiligoLast Updated:April 19, 2021Completed
Condition(s):VitiligoLast Updated:March 10, 2017Withdrawn
Condition(s):VitiligoLast Updated:April 11, 2023Completed
Condition(s):VitiligoLast Updated:February 3, 2014Completed
Condition(s):Vitiligo; Depressive Episode; Recurrent Depressive Disorder; Anxiety Disorders; Social Phobia; Adjustment Disorders; Substance Abuse; Self-Harm, Deliberate; Overdose; Suicide, Attempted; ParasuicideLast Updated:December 14, 2022Completed
Condition(s):VitiligoLast Updated:October 23, 2018Unknown status
Condition(s):VitiligoLast Updated:October 10, 2012Unknown status
Condition(s):VitiligoLast Updated:October 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.